Methods and compositions for recovery from stroke

A composition and a technology for restoring function, which are applied in the field of drugs for promoting recovery of functions, drugs for nerve function recovery, and p38-αMAPK inhibitors in subjects, which can solve the problems of unsuccessful drug preparations and the like

Inactive Publication Date: 2018-07-31
EIP PHARMA
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

To date, no pharmaceutical formulation has been successfully deve

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and compositions for recovery from stroke
  • Methods and compositions for recovery from stroke
  • Methods and compositions for recovery from stroke

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0038] Immediate treatment for patients suffering from stroke is usually impossible in clinical situations, and doctors urgently need new treatment strategies.

[0039] The present invention particularly provides compositions and methods for treating neurological injury in a subject. In particular, the present invention provides a method for promoting the recovery of function in subjects who have suffered neurological damage (for example from acute ischemic stroke) by administering a composition comprising a selective p38-αMAPK inhibitor. In some embodiments, the present invention provides a method for promoting the recovery of neurological function from ischemic injury by administering a composition comprising a selective p38-αMAPK inhibitor.

[0040] The following sections describe various aspects of the invention in detail. The use of segments is not meant to limit the invention. Each segment can be applied to any aspect of the invention. In this patent application, the use o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides methods and compositions for promoting recovery of function from neurologic injury, such as ischemic injury caused by acute stroke.

Description

[0001] Cross References to Related Applications [0002] This patent application claims the benefit of US Provisional Application No. 62 / 246,574, filed October 26, 2015, which is hereby incorporated by reference in its entirety. Background technique [0003] Stroke is the leading cause of severe long-term disability and the third leading cause of death in the United States. The total health cost of disability due to stroke is estimated at $53.6 billion per year. Ischemic stroke accounts for more than 88% of all strokes, making it the most common type of cerebrovascular injury. Ischemic conditions in the brain promote neuronal death, resulting in sensorimotor and cognitive deficits. [0004] To date, research and development of therapies for the treatment of stroke have focused on methods for preventing or reducing neuronal cell damage (ie, as "neuroprotectants" for "neuroprotection") within the immediate 24 hours of stroke . However, decades of research have yielded only ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/519A61K31/5025A61P25/00
CPCA61K31/519A61P25/00A61P43/00A61P9/10A61K9/0053
Inventor J·J·阿拉姆
Owner EIP PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products